Dsc Advisors, L.P. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $60.4 Million distributed in 34 stocks.
Among their holdings, we can observe that their the top five positions include companies like: R1 Rcm Inc. with a value of $13.4M, Cvs Health Corp with a value of $12.2M, Biomarin Pharmaceutical Inc with a value of $8.65M, Zimmer Biomet Holdings, Inc. with a value of $7.62M, and Abbott Laboratories with a value of $5.75M.
Examining the 13F form we can see an increase of $1.55M in the current position value, from $58.9M to 60.4M.
Dsc Advisors, L.P. is based out at Chicago, IL
Below you can find more details about Dsc Advisors, L.P. portfolio as well as his latest detailed transactions.